You’re interested in sponsored genetic testing with Invitae.
The Genome Medical care team features top genetic experts and primary care MDs – all dedicated to helping accelerate the integration of genetics into everyday health care. Genome Medical experts can work with you prior to testing to identify risk of disease for you and your family members and confirm eligibility for one of Invitae’s sponsored, no-charge testing programs.
Get Started With a 1-on-1 Video or Phone Consultation
$125 self-pay option, which includes
a pre- and post-test consultation
We’re a participating provider with some health insurance plans and can submit the claim to your insurance provider
As low as $50 with
How It Works
There are multiple ways to pay Genome Medical for genetic counseling when you test through Invitae’s sponsored testing programs.
(for counseling & MD services)
Self-pay: Pay $125 for Genome Medical’s services. This includes a pre-test consultation, test authorization (if applicable) and a post-test consultation to review your results. Your insurance provider will not be billed if you elect self-pay.
Insurance: We are a participating provider with some health insurance plans, and we can submit the claim to your insurance provider. The amount you pay at the time of your session will be $50 or your specialty co-pay — depending on whether we are an in-network provider with your insurance.
If you meet the eligibility criteria, you can receive no-charge testing through one of Invitae’s sponsored testing programs.
About Invitae’s Sponsored Testing
Invitae’s mission is to lower the barriers for clinicians and patients to obtain diagnostic genetic information that can lead to an earlier diagnosis. Invitae partners with biopharma companies to offer no-charge testing for individuals suspected of having one of the following disorders and who meet specific criteria:
Acute hepatic porphyrias
Hereditary ATTR amyloidosis
Inherited Retinal Disease
Lysosomal storage diseases
Primary hyperoxaluria type 1
Severe Congenital Neutropenia
Spinal muscular atrophy (SMA)